ArticleClinical pharmacology and therapeutics2016

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.

P M Coplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.